These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2846171)

  • 1. Constitutive expression of HLA class II antigens on EBV positive malignant cells from nasopharyngeal carcinoma: possible involvement in T cell infiltration.
    Busson P; Braham K; Clausse B; Tursz T
    Cancer Detect Prev; 1988; 12(1-6):363-8. PubMed ID: 2846171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X; Cai Y; Sun N
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994; 29(1):6-9. PubMed ID: 8031607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Requirement of Ia-positive accessory cells in the MLR response against class II antigen on human B cell tumor line.
    Yamamoto M; Yano A
    J Immunol; 1985 Dec; 135(6):3887-96. PubMed ID: 2999233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of Epstein-Barr viral DNA load, EBV-LMP2 specific cytotoxic T-lymphocytes and levels of CD4+CD25+ T cells in patients with nasopharyngeal carcinomas positive for IgA antibody to EBV viral capsid antigen.
    Mo WN; Tang AZ; Zhou L; Huang GW; Wang Z; Zeng Y
    Chin Med J (Engl); 2009 May; 122(10):1173-8. PubMed ID: 19493466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous B lymphoblastoid cell lines and long-term cultured T cells as stimulators in the mixed lymphocyte reaction: analysis of the role of HLA class II antigens as stimulatory molecules.
    Santoli D; Radka SF; Igarashi M; Kreider BL; Ferrone S
    J Immunol; 1986 Jul; 137(2):400-7. PubMed ID: 2941479
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells.
    Huang YT; Sheen TS; Chen CL; Lu J; Chang Y; Chen JY; Tsai CH
    Cancer Res; 1999 Apr; 59(7):1599-605. PubMed ID: 10197635
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Establishment and characterization of three transplantable EBV-containing nasopharyngeal carcinomas.
    Busson P; Ganem G; Flores P; Mugneret F; Clausse B; Caillou B; Braham K; Wakasugi H; Lipinski M; Tursz T
    Int J Cancer; 1988 Oct; 42(4):599-606. PubMed ID: 2971626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA class I expression on human ovarian carcinoma cells correlates with T-cell infiltration in vivo and T-cell expansion in vitro in low concentrations of recombinant interleukin-2.
    Kooi S; Zhang HZ; Patenia R; Edwards CL; Platsoucas CD; Freedman RS
    Cell Immunol; 1996 Dec; 174(2):116-28. PubMed ID: 8954611
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunophenotypic characterization of Epstein-Barr virus-associated gastric carcinoma: massive infiltration by proliferating CD8+ T-lymphocytes.
    Saiki Y; Ohtani H; Naito Y; Miyazawa M; Nagura H
    Lab Invest; 1996 Jul; 75(1):67-76. PubMed ID: 8683941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumorigenicity of nasopharyngeal carcinoma hybrid cell line.
    Takimoto T; Ogura H; Ohno S; Umeda R; Hatano M
    J Natl Cancer Inst; 1984 Sep; 73(3):711-5. PubMed ID: 6088881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.
    Keryer-Bibens C; Pioche-Durieu C; Villemant C; Souquère S; Nishi N; Hirashima M; Middeldorp J; Busson P
    BMC Cancer; 2006 Dec; 6():283. PubMed ID: 17156439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-surface expression of human histocompatibility leucocyte antigen (HLA) class II-associated invariant chain (CD74) does not always correlate with cell-surface expression of HLA class II molecules.
    Wilson KM; Labeta MO; Pawelec G; Fernandez N
    Immunology; 1993 Jun; 79(2):331-5. PubMed ID: 8344710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epstein-Barr virus in nontumorigenic and tumorigenic nasopharyngeal carcinoma (NPC) somatic cell hybrids.
    Staczek J; Steplewski Z; Weinmann R; Klein G; Koprowski H
    J Cell Physiol; 1981 Jun; 107(3):391-8. PubMed ID: 6265479
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.
    Shao JY; Ernberg I; Biberfeld P; Heiden T; Zeng YX; Hu LF
    Anticancer Res; 2004; 24(4):2309-18. PubMed ID: 15330177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of HLA class II antigens in fetal human spleen: relationship of HLA-DP, DQ, and DR to immunoglobulin expression.
    Edwards JA; Durant BM; Jones DB; Evans PR; Smith JL
    J Immunol; 1986 Jul; 137(2):490-7. PubMed ID: 3522732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes.
    Comoli P; Pedrazzoli P; Maccario R; Basso S; Carminati O; Labirio M; Schiavo R; Secondino S; Frasson C; Perotti C; Moroni M; Locatelli F; Siena S
    J Clin Oncol; 2005 Dec; 23(35):8942-9. PubMed ID: 16204009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change and effect of Epstein Barr virus (EBV) antigen induced T8 cells in nasopharyngeal carcinoma patients and EBV seropositive individuals].
    Huang PC
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):12-6. PubMed ID: 8392927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA expression in basal cell carcinomas.
    Garcia-Plata D; Mozos E; Sierra MA; Peña J; Solana R
    Invasion Metastasis; 1991; 11(3):166-73. PubMed ID: 1834604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of HLA-DR, -DQ, and -DP antigens on malignant B cells.
    Pesando JM; Graf L
    J Immunol; 1986 Jun; 136(11):4311-8. PubMed ID: 2939141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.